Drug Shortage Report for TEVA-IRBESARTAN HCTZ
| Report ID | 209122 |
| Drug Identification Number | 02330539 |
| Brand name | TEVA-IRBESARTAN HCTZ |
| Common or Proper name | TEVA-IRBESARTAN/HCTZ 300/25MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | IRBESARTAN HYDROCHLOROTHIAZIDE |
| Strength(s) | 300MG 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-01 |
| Estimated end date | 2024-03-10 |
| Actual end date | 2024-03-06 |
| Shortage status | Resolved |
| Updated date | 2024-03-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2024-03-07 | French | Compare |
| v16 | 2024-03-07 | English | Compare |
| v15 | 2024-02-29 | French | Compare |
| v14 | 2024-02-29 | English | Compare |
| v13 | 2024-02-15 | French | Compare |
| v12 | 2024-02-15 | English | Compare |
| v11 | 2024-02-01 | French | Compare |
| v10 | 2024-02-01 | English | Compare |
| v9 | 2024-01-18 | French | Compare |
| v8 | 2024-01-18 | English | Compare |
| v7 | 2024-01-11 | French | Compare |
| v6 | 2024-01-11 | English | Compare |
| v5 | 2023-11-16 | French | Compare |
| v4 | 2023-11-16 | English | Compare |
| v3 | 2023-11-16 | English | Compare |
| v2 | 2023-11-03 | French | Compare |
| v1 | 2023-11-03 | English | Compare |
Showing 1 to 17 of 17